Référentiel des médicaments
Revakinagene taroretcel
Revakinagene taroretcel is a medicine in the class miscellaneous.
- Classe médicamenteuse: Miscellaneous
Dernière mise à jour Sources: US FDA label
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Miscellaneous
- Noms commerciaux
- 1
- Pays et marchés
- 1
Mécanisme d'action
The implant secretes recombinant human ciliary neurotrophic factor (rhCNTF). Exogenous CNTF is thought to target Müller glia and trigger signaling that may promote photoreceptor survival. The mechanism is not completely understood.
Posologie adulte habituelle (résumé de la notice)
Idiopathic macular telangiectasia type 2: one implant per affected eye (200,000 to 440,000 allogeneic RPE cells expressing rhCNTF), single surgical intravitreal implantation by a qualified ophthalmologist
Grossesse et allaitement
- Grossesse
- Unknown An eye implant of cells releasing ciliary neurotrophic factor (CNTF); no data in pregnant women, and not known if it raises CNTF above natural levels. CNTF under the skin caused no birth defects in rats or rabbits, but fewer implantations and live fetuses in rabbits. Use only if clearly needed.
- Allaitement
- Unknown No data on milk or infant effects; no LactMed record. Systemic exposure from the eye implant is not known to rise above natural CNTF levels. US label: weigh benefits of breastfeeding against the mother's need.
Effets indésirables signalés
- Conjunctival hemorrhage
- Delayed dark adaptation
- Foreign body sensation
- Eye pain
- Suture related complications
- Miosis
Contre-indications
- Active or suspected ocular or periocular infections
- Known hypersensitivity to Endothelial Serum Free Media (Endo-SFM)
Précautions particulières
- Severe vision loss (3 or more lines, ≥15 ETDRS letters) has occurred; monitor patients
- Infectious endophthalmitis may occur; use aseptic technique, monitor, and remove the implant if it occurs
- Retinal tears and detachment may occur; monitor and treat promptly; remove implant if vitrectomy with complete gas or silicone oil fill is required
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Revakinagene taroretcel : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- How to give it
- Pharmacokinetics
- Patient counselling points
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Autres médicaments de cette classe
Questions fréquentes
What is Revakinagene taroretcel used for?
Revakinagene taroretcel is a medicine in the class miscellaneous.
What side effects have been reported with Revakinagene taroretcel?
Conjunctival hemorrhage, Delayed dark adaptation, Foreign body sensation, Eye pain, Suture related complications, Miosis.
Can Revakinagene taroretcel be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. An eye implant of cells releasing ciliary neurotrophic factor (CNTF); no data in pregnant women, and not known if it raises CNTF above natural levels. CNTF under the skin caused no birth defects in rats or rabbits, but fewer implantations and live fetuses in rabbits. Use only if clearly needed. Breastfeeding: Unknown. No data on milk or infant effects; no LactMed record. Systemic exposure from the eye implant is not known to rise above natural CNTF levels. US label: weigh benefits of breastfeeding against the mother's need.
What does Revakinagene taroretcel interact with?
MediHelp does not list a checked interaction for Revakinagene taroretcel yet. Always tell your pharmacist about every medicine you take.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
